封面
市场调查报告书
商品编码
1605365

伴同性动物保健市场规模、份额、成长分析、按产品类型、按动物类型、按分销管道、按地区 - 行业预测,2024-2031 年

Companion Animal Health Market Size, Share, Growth Analysis, By Product Type (Vaccines, Pharmaceuticals), By Animal Type (Dog, Cat), By Distribution Channel, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 165 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球伴同性动物保健市场规模为191亿美元,从2023年的204亿美元成长到2031年的345.3亿美元,复合年增长率预计为6.80%。

在公共和私营部门旨在改善动物健康的联合倡议的推动下,动物用药品市场预计将显着增长。特别是,由美国兽医协会 (AVMA)、联合国粮食及农业组织 (FAO) 和世界动物卫生组织 (OIE) 等组织参与的「管治健康倡议」旨在努力控制通用感染疾病,保护公众健康。随着宠物饲养方式的发展,宠物变得更加人性化,人们对宠物健康和安全的担忧也随之增加,饲主也对宠物的健康投入了更多的精力。随着人类与动物之间的情感连结越来越紧密,消费者在宠物照护上的支出也越来越多。美国对宠物健康保险的需求不断增长,进一步放大了这一趋势,反映出保护宠物健康的积极主动的做法。凭藉这些新兴的市场动态,动物保健市场的相关人员处于有利位置,可以利用人们对综合宠物护理和健康管理的日益关注,提高消费者的意识和需求。推动力。

目录

介绍

  • 研究目的
  • 调查范围
  • 定义

调查方法

  • 资讯采购
  • 二手资料和主要资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 抑制因素和挑战
  • 波特分析及影响
    • 竞争公司之间的敌对关係
    • 替代品的威胁
    • 买方议价能力
    • 新进入者的威胁
    • 供应商的议价能力

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2023)
  • PESTEL分析
  • 总体经济指标
  • 价值链分析
  • 价格分析
  • 技术进步
  • 监管环境
  • 案例研究

伴同性动物保健市场规模:依产品类型及复合年增长率(2024-2031)

  • 市场概况
  • 疫苗
  • 药品
    • OTC
    • 处方笺
  • 饲料添加剂
  • 诊断
  • 其他的

伴同性动物保健市场规模:以动物类型和复合年增长率(2024-2031)

  • 市场概况
  • 其他宠物

伴同性动物保健市场规模:依通路及复合年增长率(2024-2031)

  • 市场概况
  • 零售
  • 电子商务
  • 医院药房

伴同性动物保健市场规模:依最终用户和复合年增长率(2024-2031)

  • 市场概况
  • 动物医院/诊所
  • 诊断实验室
  • 研究机构和大学
  • 居家照护设置

伴同性动物保健市场规模:按地区和复合年增长率(2024-2031)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲

竞争资讯

  • 前5名企业对比
  • 主要企业市场定位(2023年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析(2023)
  • 主要企业简介
    • 公司简介
    • 产品系列分析
    • 按细分市场分類的份额分析
    • 收益与前一年同期比较(2021-2023)

主要企业简介

  • Boehringer Ingelheim International GmbH
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • IDEXX Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Biomerieux SA
  • Virbac
  • Norbrook Laboratories Limited
  • Neogen Corporation
  • Fujifilm Holdings Corporation
  • Indical Bioscience GmbH
  • Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • Bionote
  • Skyla Corporation
  • Euroimmun Medizinische Labordiagnostika Ag
  • Urit Medical Electronic Co., Ltd
  • Nova Biomedical
  • Fassisi Gmbh
  • Alvedia
  • Agrolabo SPA

结论和建议

简介目录
Product Code: SQMIG25R2002

Global Companion Animal Health Market size was valued at USD 19.10 billion in 2022 and is poised to grow from USD 20.40 billion in 2023 to USD 34.53 billion by 2031, growing at a CAGR of 6.80% during the forecast period (2024-2031).

The market for animal health is set to experience significant growth, driven by collaborative initiatives from both public and private sectors aimed at enhancing animal health. Notably, the One Health Initiative, involving organizations such as the American Veterinary Medical Association (AVMA), Food and Agriculture Organization (FAO), and World Organization for Animal Health (OIE), seeks to protect public health by managing zoonotic diseases through effective policy implementation at various governance levels. As pet ownership evolves, the humanization of pets has sparked heightened concerns regarding their health and safety, influencing owners to invest more in their well-being. The growing emotional bond between humans and animals has catalyzed consumer willingness to allocate a larger budget for pet care. This trend is further amplified by the rising demand for pet health insurance in the United States, reflecting a proactive approach towards safeguarding pet health. With these developing dynamics, stakeholders in the animal health market are well-positioned to capitalize on the increasing focus on comprehensive pet care and health management, presenting lucrative opportunities as investments in animal health continue to gain traction amid rising consumer awareness and demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Companion Animal Health market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Companion Animal Health Market Segmental Analysis

Due to the increasing pet population, rising investment in the healthcare sector, and the presence of top healthcare service providers, North America held the greatest revenue share of more than 40% in 2021 and is anticipated to hold the lead during the forecast period. Additionally, the rise of the animal healthcare market in this region is projected to be fueled by technology advancements, increase in pet ownership, and increase in the frequency of zoonotic diseases.

Driver of the Global Companion Animal Health Market

The Companion Animal Health market is significantly influenced by several key factors. A notable driver is the rising adoption of artificial intelligence, which enhances diagnostic capabilities and drives industry growth. In the United States, the increasing number of companion animals is expected to fuel market expansion further. Additionally, the growing availability of insurance policies to cover accidents is projected to contribute positively to the sector. The rise in cancer cases among dogs also plays a crucial role in driving demand. Other contributing factors include the expansion of veterinary practices, urbanization, and heightened consumer demand for animal healthcare products. Investment in pharmaceutical development to enhance drug and vaccine quality, combined with societal shifts towards nuclear families and increased government support for veterinary care, are vital elements propelling the market forward.

Restraints in the Global Companion Animal Health Market

The Global Companion Animal Health market is currently facing several significant restraints. The growing awareness of zoonotic diseases has resulted in a surge of abandoned pets as people fear transmitting viruses from animals to humans. Additionally, the COVID-19 pandemic disrupted supply chains, leading to shortages of essential animal health products such as vaccines and feed. Furthermore, stringent government regulations restricting the importation of raw materials from China are expected to hinder market growth. Moreover, the lack of market standardization and the high costs associated with products and diagnostics pose additional challenges, ultimately limiting the expansion of the companion animal health sector.

Market Trends of the Global Companion Animal Health Market

The Global Companion Animal Health market is witnessing a significant trend towards personalization and premium services, driven by the evolving needs of pet owners. Grooming centers, daycare facilities, and pet-friendly establishments are increasingly offering bespoke services tailored to the specific requirements of pets, including skin and fur treatments and customized accessories. The rise of start-ups in regions like India is further enhancing this trend by providing innovative online services that cater to pet ownership, veterinary advice, and even travel planning for pet owners. Additionally, the emergence of health monitoring and training apps is reinforcing the focus on pet wellness, positioning personalized care as a key driver in the companion animal health sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Case Studies

Global Companion Animal Health Market Size by Product Type & CAGR (2024-2031)

  • Market Overview
  • Vaccines
  • Pharmaceuticals
    • OTC
    • Prescription
  • Feed Additives
  • Diagnostics
  • Others

Global Companion Animal Health Market Size by Animal Type & CAGR (2024-2031)

  • Market Overview
  • Dog
  • Cat
  • Horse
  • Other Companion Animals

Global Companion Animal Health Market Size by Distribution Channel & CAGR (2024-2031)

  • Market Overview
  • Retail
  • E-commerce
  • Hospital pharmacies

Global Companion Animal Health Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Veterinary Hospitals & Clinics
  • Diagnostics Laboratories
  • Research Institutes & Universities
  • Home-care Settings

Global Companion Animal Health Market Size & CAGR (2024-2031)

  • North America, (Product Type, Animal Type, Distribution Channel, End User)
    • US
    • Canada
  • Europe, (Product Type, Animal Type, Distribution Channel, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Product Type, Animal Type, Distribution Channel, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Product Type, Animal Type, Distribution Channel, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Product Type, Animal Type, Distribution Channel, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Boehringer Ingelheim International GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zoetis Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elanco Animal Health Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IDEXX Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomerieux SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virbac
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Norbrook Laboratories Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neogen Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Holdings Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Indical Bioscience GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shenzhen Mindray Animal Medical Technology Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bionote
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Skyla Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Euroimmun Medizinische Labordiagnostika Ag
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Urit Medical Electronic Co., Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nova Biomedical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fassisi Gmbh
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alvedia
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agrolabo S.P.A
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation